Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

Cited by (1,086)

Items 401–500 of 1,086

1. Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases
   María Teresa Flores-Dorantes, Yael E. Díaz‐López, Ruth Gutiérrez‐Aguilar · 2020 · Frontiers in Neuroscience
2. Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases
   Rachel J. Boyd, Dimitrios Avramopoulos, Lauren L. Jantzie, Andrew S. McCallion · 2022 · Journal of Neuroinflammation
3. Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci
   Tin Aung, Mineo Ozaki, Mei Lee, Ursula M. Schlötzer-Schrehardt, Guðmar Þorleifsson, Takanori Mizoguchi, Robert P. Igo, Aravind Haripriya, Susan Eileen Isabella Williams, Yury Sergeevich Astakhov et al. · 2017 · Nature Genetics
4. Excessive tubulin polyglutamylation causes neurodegeneration and perturbs neuronal transport
   Maria M. Magiera, Satish Bodakuntla, Jakub Žiak, Sabrina Lacomme, Patricia Marques Sousa, Sophie Leboucher, Torben Johann Hausrat, Christophe Bosc, Annie Andrieux, Matthias Kneussel et al. · 2018 · The EMBO Journal
5. Association of relative brain age with tobacco smoking, alcohol consumption, and genetic variants
   Kaida Ning, Lu Zhao, William J. Matloff, Fengzhu Sun, Arthur W. Toga · 2020 · Scientific Reports
6. Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis – What do we need to know?
   Herbert, Joe, Lucassen, Paul J. · 2016 · Frontiers in Neuroendocrinology
7. New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease
   Fuller, James P., Stavenhagen, Jeffrey B., Teeling, Jessica L. · 2014 · Frontiers in Neuroscience
8. Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
   Mariet Allen, Michaela Kachadoorian, Zachary Quicksall, Fanggeng Zou, High Seng Chai, Curtis S. Younkin, Julia E. Crook, V. Shane Pankratz, Minerva M. Carrasquillo, Siddharth Krishnan et al. · 2014 · Alzheimer s Research & Therapy
9. Is Alzheimer’s Disease Risk Modifiable?
   Alberto Serrano‐Pozo, John H. Growdon · 2019 · Journal of Alzheimer s Disease
10. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease
    McKenzie, Andrew T., Moyon, Sarah, Wang, Minghui, Katsyv, Igor, Song, Won-Min, Zhou, Xianxiao, Dammer, Eric B., Duong, Duc M., Aaker, Joshua, Zhao, Yongzhong et al. · 2017 · Molecular Neurodegeneration
11. A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death
    Alzheimer's Disease Genetics Consortium, Wetzel-Smith, Monica K, Hunkapiller, Julie, Bhangale, Tushar R, Srinivasan, Karpagam, Maloney, Janice A, Atwal, Jasvinder K, Sa, Susan M, B Yaylaoglu, Murat, Foreman, Oded et al. · 2014 · Nature Medicine
12. Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways
    Samantha L. Rosenthal, M. Ilyas Kamboh · 2014 · Current Genetic Medicine Reports
13. Mendelian Randomization Implicates High-Density Lipoprotein Cholesterol–Associated Mechanisms in Etiology of Age-Related Macular Degeneration
    Stephen Burgess, George Davey Smith · 2017 · Ophthalmology
14. Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
    Heng‐Chung Kung, Kai-Jung Lin, Chia‐Te Kung, Tsu‐Kung Lin · 2021 · Biomedicines
15. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study
    Cuyvers, Elise, De Roeck, Arne, Van den Bossche, Tobi, Van Cauwenberghe, Caroline, Bettens, Karolien, Vermeulen, Steven, Mattheijssens, Maria, Peeters, Karin, Engelborghs, Sebastiaan, Vandenbulcke, Mathieu et al. · 2015 · The Lancet Neurology
16. Periodontal disease as a possible cause for Alzheimer's disease
    Angela R. Kamer, Ronald G. Craig, Richard Niederman, Juan Fortea, Mony J. de Leon · 2020 · Periodontology 2000
17. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors
    Lagomarsino, Valentina N., Pearse, Richard V., Liu, Lei, Hsieh, Yi-Chen, Fernandez, Marty A., Vinton, Elizabeth A., Paull, Daniel, Felsky, Daniel, Tasaki, Shinya, Gaiteri, Chris et al. · 2021 · Neuron
18. Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease
    Desikan, Rahul S., Schork, Andrew J., Wang, Yunpeng, Thompson, Wesley K., Dehghan, Abbas, Ridker, Paul M, Chasman, Daniel I., McEvoy, Linda K., Holland, Dominic, Chen, Chi-Hua et al. · 2015 · Circulation
19. Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
    Whyte, Lauren S., Lau, Adeline A., Hemsley, Kim M., Hopwood, John J., Sargeant, Timothy J. · 2017 · Journal of Neurochemistry
20. Rare coding mutations identified by sequencing of <scp>A</scp>lzheimer disease genome‐wide association studies loci
    Vardarajan, Badri N., Ghani, Mahdi, Kahn, Amanda, Sheikh, Stephanie, Sato, Christine, Barral, Sandra, Lee, Joseph H., Cheng, Rong, Reitz, Christiane, Lantigua, Rafael et al. · 2015 · Annals of Neurology
21. Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus
    Rahul S. Desikan, Andrew Joseph Schork, Yibin Wang, Aree Witoelar, Manu Sharma, Linda K. McEvoy, Dominic Holland, James B. Brewer, Chun‐Houh Chen, Wesley Kurt Thompson et al. · 2015 · Molecular Psychiatry
22. Education, intelligence and Alzheimer’s disease: evidence from a multivariable two-sample Mendelian randomization study
    Emma Louise Anderson, Laura D Howe, Kaitlin Hazel Wade, Yoav Ben‐Shlomo, William David Hill, Ian J. Deary, Eleanor C. M. Sanderson, Jie Zheng, Roxanna Korologou‐Linden, Evie Stergiakouli et al. · 2020 · International Journal of Epidemiology
23. The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases
    Fengzhe Xu, Yuanqing Fu, Ting‐yu Sun, Zengliang Jiang, Zelei Miao, Menglei Shuai, Wanglong Gou, Chu-wen Ling, Jian Yang, Jun Wang et al. · 2020 · Microbiome
24. Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes
    Rhinn, Herve, Abeliovich, Asa · 2017 · Cell Systems
25. A Precision Medicine Initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling
    Hampel, H., O’Bryant, S. E., Durrleman, S., Younesi, E., Rojkova, K., Escott-Price, V., Corvol, J-C., Broich, K., Dubois, B., Lista, S. et al. · 2017 · Climacteric
26. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology
    Nobutaka Sakae, Chia‐Chen Liu, Mitsuru Shinohara, Jessica L. Frisch‐Daiello, Li Ma, Yu Yamazaki, Masaya Tachibana, Linda H. Younkin, Aishe Kurti, Minerva M. Carrasquillo et al. · 2016 · Journal of Neuroscience
27. Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry
    Hon‐Cheong So, Carlos Kwan‐Long Chau, Wan-To Chiu, Kin-Sang Ho, Cho-Pong Lo, Stephanie Ho-Yue Yim, Pak Chung Sham · 2017 · Nature Neuroscience
28. A critique of life history approaches to human trait covariation
    Brendan P. Zietsch, Morgan J. Sidari · 2019 · Evolution and Human Behavior
29. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer’s disease
    Laura T. Haas, Santiago V. Salazar, Mikhail A. Kostylev, Ji Won Um, Adam C. Kaufman, Stephen M. Strittmatter · 2015 · Brain
30. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia
    Russell Lewis McLaughlin, Dick Schijven, Wouter van Rheenen, Kristel R. van Eijk, Margaret O’Brien, René S. Kahn, Roel A. Ophoff, An Goris, Daniel G. Bradley, Ammar Al‐Chalabi et al. · 2017 · Nature Communications
31. Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer’s disease
    Angela Jeong, Kiall F. Suazo, W. Gibson Wood, Mark Dewey Distefano, Ling Li · 2018 · Critical Reviews in Biochemistry and Molecular Biology
32. Prioritizing Parkinson’s disease genes using population-scale transcriptomic data
    Li, Yang I., Wong, Garrett, Humphrey, Jack, Raj, Towfique · 2019 · Nature Communications
33. Whole-Genome and RNA Sequencing Reveal Variation and Transcriptomic Coordination in the Developing Human Prefrontal Cortex
    Donna M. Werling, Sirisha Pochareddy, Jinmyung Choi, Joon‐Yong An, Brooke K. Sheppard, Minshi Peng, Zhen Li, Claudia Dastmalchi, Gabriel Santpere, André M. M. Sousa et al. · 2020 · Cell Reports
34. Human iPSC‐derived microglia: A growing toolset to study the brain's innate immune cells
    Hasselmann, Jonathan, Blurton‐Jones, Mathew · 2020 · Glia
35. Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
    Amand Floriaan Schmidt, Nicholas B. Hunt, María Gordillo‐Marañón, Pimphen Charoen, Fotios Drenos, Juan Pablo Casas, Mika Kivimaki B, Debbie A. Lawlor, Claudia Giambartolomei, Olia Papacosta et al. · 2021 · Nature Communications
36. Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
    Minghui Wang, Hu Zhang, Jiling Liang, Jielun Huang, Ning Chen · 2023 · Journal of Neuroinflammation
37. Inferring relevant cell types for complex traits by using single-cell gene expression
    Calderon, Diego, Bhaskar, Anand, Knowles, David A., Golan, David, Raj, Towfique, Fu, Audrey Q., Pritchard, Jonathan K. · 2017 · The American Journal of Human Genetics
38. Phenome-wide analysis of genome-wide polygenic scores
    Eva M. L. Krapohl, Jack Euesden, Delilah Zabaneh, Jean‐Baptiste Pingault, Kaili Rimfeld, Sophie von Stumm, Philip S. Dale, Gerome D. Breen, Paul F. O’Reilly, Robert J. Plomin · 2015 · Molecular Psychiatry
39. Neuroinflammatory responses in Alzheimer’s disease
    Cira Dansokho, Michael Thomas Heneka · 2017 · Journal of Neural Transmission
40. Genetic variants and functional pathways associated with resilience to Alzheimer’s disease
    Logan C. Dumitrescu, Emily R. Mahoney, Shubhabrata Mukherjee, Michael L. Lee, William S. Bush, Corinne D. Engelman, Qiongshi Lu, David W. Fardo, Emily H. Trittschuh, Jesse B Mez et al. · 2020 · Brain
41. Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence
    Harald Juergen Hampel, Robert Nisticò, Nicholas T. Seyfried, Allan I. Levey, Erica S. Modeste, Pablo Lemercier, Filippo Baldacci, Nicola Toschi, Francesco Garaci, George L. Perry et al. · 2021 · Ageing Research Reviews
42. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
    Kristi Henjum, Ina S. Almdahl, Vibeke Årskog, Lennart Minthon, Oskar Hansson, Tormod Fladby, Lars N. G. Nilsson · 2016 · Alzheimer s Research & Therapy
43. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases
    Cornelis Blauwendraat, Faraz Faghri, Lasse Pihlstrøm, Joshua T. Geiger, Alexis Elbaz, Suzanne Lesage, Jean‐Christophe Corvol, Patrick May, Aude Nicolas, Yevgeniya A. Abramzon et al. · 2017 · Neurobiology of Aging
44. Stem cell models of Alzheimer’s disease: progress and challenges
    Arber, Charles, Lovejoy, Christopher, Wray, Selina · 2017 · Alzheimer's Research &amp; Therapy
45. Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer’s disease
    Xinzhong Li, Jintao Long, Taigang He, Robert D. Belshaw, James Scott · 2015 · Scientific Reports
46. Advanced brain aging: relationship with epidemiologic and genetic risk factors, and overlap with Alzheimer disease atrophy patterns
    Mohamad Habes, Deborah Janowitz, Güray Erus, Jon B. Toledo, Susan M. Resnick, Jimit J. Doshi, Sandra Van der Auwera, Katharina Wittfeld, Katrin Hegenscheid, Norbert Hosten et al. · 2016 · Translational Psychiatry
47. Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania
    Tom Parks, Mariana Mirabel, Joseph H. Kado, Kathryn Auckland, Jarosław Nowak, Anna Rautanen, Alexander J. Mentzer, Éloi Marijon, Xavier Jouven, Mai Ling Perman et al. · 2017 · Nature Communications
48. Stem Cells, Genome Editing, and the Path to Translational Medicine
    Frank Soldner, Rudolf Jaenisch · 2018 · Cell
49. Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease
    Christopher H. van Dyck, Haakon B. Nygaard, Kewei Chen, Michael Donohue, Rema Raman, Robert A. Rissman, James B. Brewer, Robert A. Koeppe, Tiffany W. Chow, Michael S. Rafii et al. · 2019 · JAMA Neurology
50. Biological and environmental predictors of heterogeneity in neurocognitive ageing
    Lars H Nyberg, Carl‐Johan Boraxbekk, Daniel Eriksson Sörman, Patrik Hansson, Agneta Herlitz, Karolina Kauppi, Jessica K. Ljungberg, Hugo Lövheim, Anders Lundquist, Annelie Nordin Adolfsson et al. · 2020 · Ageing Research Reviews
51. Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response
    Pimenova, Anna A., Herbinet, Manon, Gupta, Ishaan, Machlovi, Saima I., Bowles, Kathryn R., Marcora, Edoardo, Goate, Alison M. · 2021 · Neurobiology of Disease
52. Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer's disease
    Raghavan, Neha S., Brickman, Adam M., Andrews, Howard, Manly, Jennifer J., Schupf, Nicole, Lantigua, Rafael, Wolock, Charles J., Kamalakaran, Sitharthan, Petrovski, Slave, Tosto, Giuseppe et al. · 2018 · Annals of Clinical and Translational Neurology
53. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
    Fang, Jiansong, Zhang, Pengyue, Wang, Quan, Chiang, Chien-Wei, Zhou, Yadi, Hou, Yuan, Xu, Jielin, Chen, Rui, Zhang, Bin, Lewis, Stephen J. et al. · 2022 · Alzheimer's Research &amp; Therapy
54. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer’s disease
    Broce, Iris J., Tan, Chin Hong, Fan, Chun Chieh, Jansen, Iris, Savage, Jeanne E., Witoelar, Aree, Wen, Natalie, Hess, Christopher P., Dillon, William P., Glastonbury, Christine M. et al. · 2019 · Acta Neuropathologica
55. TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex Traits
    Sini Nagpal, Xiaoran Meng, Michael P. Epstein, Lam C. Tsoi, Matthew T. Patrick, Greg C. Gibson, Philip L. De Jager, David Alan Bennett, Aliza P. Wingo, Thomas S. Wingo et al. · 2019 · The American Journal of Human Genetics
56. Prediction of Alzheimer’s disease using blood gene expression data
    Taesic Lee, Hyunju Lee · 2020 · Scientific Reports
57. Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer’s disease
    Zhang, Lanyu, Silva, Tiago C., Young, Juan I., Gomez, Lissette, Schmidt, Michael A., Hamilton-Nelson, Kara L., Kunkle, Brian W., Chen, Xi, Martin, Eden R., Wang, Lily · 2020 · Nature Communications
58. Cardiac cell type–specific gene regulatory programs and disease risk association
    James D. Hocker, Olivier Poirion, Fugui Zhu, Justin Buchanan, Kai Zhang, Joshua Chiou, Tsui‐Min Wang, Qingquan Zhang, Xiaomeng Hou, Yang Eric Li et al. · 2021 · Science Advances
59. Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study
    Xin You Tai, Michele Veldsman, Donald M. Lyall, Thomas J. Littlejohns, Kenneth M. Langa, Masud Husain B, Janice M. Ranson, David J. Llewellyn · 2022 · The Lancet Healthy Longevity
60. Polygenic risk score of sporadic late‐onset Alzheimer's disease reveals a shared architecture with the familial and early‐onset forms
    Cruchaga, Carlos, Del‐Aguila, Jorge L., Saef, Benjamin, Black, Kathleen, Fernandez, Maria Victoria, Budde, John, Ibanez, Laura, Deming, Yuetiva, Kapoor, Manav, Tosto, Giuseppe et al. · 2018 · Alzheimer's &amp; Dementia
61. Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease
    Daniel L. McCartney, Anna J. Stevenson, Rosie May Walker, Jude Gibson, Stewart W. Morris, Archie Campbell, Alison D. Murray, Heather Clare Whalley, David John Porteous, Andrew Mark McIntosh et al. · 2018 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
62. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer’s disease
    Berchtold, Nicole C., Sabbagh, Marwan N., Beach, Thomas G., Kim, Ronald C., Cribbs, David H., Cotman, Carl W. · 2014 · Neurobiology of Aging
63. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins
    Srikant Rangaraju, Eric B. Dammer, Syed Ali Raza, Tianwen Gao, Hailian Xiao, Ranjita S. Betarbet, Duc Minh Duong, James A. Webster, Chadwick M. Hales, James J. Lah et al. · 2018 · Molecular Neurodegeneration
64. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer’s disease donor as a model for investigating AD-associated gene regulatory networks
    A. Hossini, M. Megges, A. Prigione, Bjoern Lichtner, M. Toliat, W. Wruck, F. Schröter, P. Nuernberg, H. Kroll, E. Makrantonaki et al. · 2015 · BMC Genomics
65. Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
    Roy Lardenoije, Janou A. Y. Roubroeks, Ehsan Pishva, Markus Leber, Holger Wagner, Artemis Iatrou, Adam R. Smith, Rebecca G. Smith, Lars Eijssen, Luca Kleineidam et al. · 2019 · Clinical Epigenetics
66. Drug development for alzheimer’s disease: Microglia induced neuroinflammation as a target
    Dong, Yuan, Li, Xiaoheng, Cheng, Jinbo, Hou, Lin · 2019 · International Journal of Molecular Sciences
67. GWAS of longitudinal amyloid accumulation on¹⁸F-florbetapir PET in Alzheimer’s disease implicates microglial activation gene<i>IL1RAP</i>
    Ramanan, Vijay K, Risacher, Shannon L., Nho, Kwangsik, Kim, Sungeun, Shen, Li, McDonald, Brenna C., Yoder, Karmen K., Hutchins, Gary D., West, John D., Tallman, Eileen F. et al. · 2015 · Brain
68. Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy
    Henne H. Holstege, Sven J. van der Lee, Marc Hulsman, Tsz Hang Wong, Jeroen van Rooij, Marjan M. Weiss, Eva Louwersheimer, Frank J. Wolters, Najaf Amin, André Gerardus Uitterlinden et al. · 2017 · European Journal of Human Genetics
69. Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
    Seto, Mabel, Weiner, Rebecca L., Dumitrescu, Logan, Hohman, Timothy J. · 2021 · Molecular Neurodegeneration
70. Zebrafish as a model organism for neurodegenerative disease
    Kelda Chia, Anna Klingseisen, Dirk Sieger, Josef Priller · 2022 · Frontiers in Molecular Neuroscience
71. The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?
    Kehoe, Patrick Gavin · 2018 · Journal of Alzheimer’s Disease
72. Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer’s disease
    Petroula Proitsi, M Kim, Luke Whiley, Megan Pritchard, R Leung, Hilkka S. Soininen, Iwona Kłoszewska, Patrizia Mecocci, Magda Tsolaki, Bruno J. Vellas et al. · 2015 · Translational Psychiatry
73. Microglial Malfunction: The Third Rail in the Development of Alzheimer's Disease
    Mhatre, Siddhita D., Tsai, Connie A., Rubin, Amanda J., James, Michelle L., Andreasson, Katrin I. · 2015 · Trends in Neurosciences
74. Alzheimer’s disease variants with the genome-wide significance are significantly enriched in immune pathways and active in immune cells
    Jiang, Qinghua, Jin, Shuilin, Jiang, Yongshuai, Liao, Mingzhi, Feng, Rennan, Zhang, Liangcai, Liu, Guiyou, Hao, Junwei · 2017 · Molecular Neurobiology
75. The genetic landscape of Alzheimer disease
    Susana Carmona, John Hardy, Rita João Guerreiro · 2018 · Handbook of clinical neurology
76. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits
    Koutsodendris, Nicole, Blumenfeld, Jessica, Agrawal, Ayushi, Traglia, Michela, Grone, Brian, Zilberter, Misha, Yip, Oscar, Rao, Antara, Nelson, Maxine R., Hao, Yanxia et al. · 2023 · Nature Aging
77. Genome-wide association study of CSF levels of 59 Alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation
    Kauwe, John S. K., Bailey, Matthew H., Ridge, Perry G., Perry, Rachel, Wadsworth, Mark E., Hoyt, Kaitlyn L., Staley, Lyndsay A., Karch, Celeste M., Harari, Oscar, Cruchaga, Carlos et al. · 2014 · PLoS Genetics
78. Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer’s Disease
    Burcu F. Darst, Rebecca L. Koscik, Annie Marie Racine, Jennifer M. Oh, Rachel A. Krause, Cynthia M. Carlsson, Henrik Zetterberg, Kaj Blennow, Bradley T. Christian, Barbara B. Bendlin et al. · 2016 · Journal of Alzheimer s Disease
79. The relationship between sleep duration, cognition and dementia: a Mendelian randomization study
    Albert Henry, Michail Katsoulis, Stefano Masi, Ghazaleh Fatemifar, Spiros Denaxas, Dionisio Acosta, Victoria Garfield, Caroline E Dale · 2019 · International Journal of Epidemiology
80. Independent and Reproducible Hippocampal Radiomic Biomarkers for Multisite Alzheimer's Disease: Diagnosis, Longitudinal Progress and Biological Basis
    Kun Zhao, Yanhui Ding, Ying Han, Yong Fan A, Aaron F. Alexander‐Bloch, Tong Han, Dan Jin, Bing Liu, Jie Lu, Chengyuan Song et al. · 2019 · 中国科学通报：英文版
81. Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes
    Yue Liu, Anbupalam Thalamuthu, Karen A. Mather, John D. Crawford, Marina Ulanova, Matthew Wai Kin Wong, Russell Pickford, Perminder Singh Sachdev, Nady Braidy · 2021 · Translational Psychiatry
82. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model
    Qian Shi, Cheng Chang, Afaf Saliba, Manzoor A. Bhat · 2022 · Journal of Neuroscience
83. Amyloid Precursor Protein and Alzheimer’s Disease
    Orobets, Kseniia S., Karamyshev, Andrey L. · 2023 · International Journal of Molecular Sciences
84. Functional regulatory variants implicate distinct transcriptional networks in dementia
    Yonatan A. Cooper, Noam Teyssier, Nina M. Dräger, Qiuyu Guo, Jessica E. Davis, Sydney M. Sattler, Zhongan Yang, Abdulsamie M. Patel, Sarah J. Wu, Sriram Kosuri et al. · 2022 · Science
85. SORL1 rare variants: a major risk factor for familial early-onset Alzheimer’s disease
    Nicolas, G, Charbonnier, C, Wallon, D, Quenez, O, Bellenguez, C, Grenier-Boley, B, Rousseau, S, Richard, A-C, Rovelet-Lecrux, A, Le Guennec, K et al. · 2016 · Molecular Psychiatry
86. Loss‐of‐function mutation in <i>ABCA1</i> and risk of Alzheimer's disease and cerebrovascular disease
    Nordestgaard, Liv Tybjærg, Tybjærg‐Hansen, Anne, Nordestgaard, Børge G., Frikke‐Schmidt, Ruth · 2015 · Alzheimer's &amp; Dementia
87. Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation
    Catherine Do, Charles F. Lang, J. P. Lin, Huferesh K. Darbary, Izabela Krupska, Aulona Gaba, Lynn Petukhova, Jean‐Paul Vonsattel, MARY PAT GALLAGHER, Robin Goland et al. · 2016 · The American Journal of Human Genetics
88. Whole-genome analyses of whole-brain data: working within an expanded search space
    Medland, Sarah E, Jahanshad, Neda, Neale, Benjamin M, Thompson, Paul M · 2014 · Nature Neuroscience
89. The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease
    Kokiko-Cochran, Olga N., Godbout, Jonathan P. · 2018 · Frontiers in Immunology
90. Complement dysregulation in the central nervous system during development and disease
    John D. Lee, Liam G. Coulthard, Trent M. Woodruff · 2019 · Seminars in Immunology
91. DNA methylation signatures of Alzheimer’s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types
    Gemma L. Shireby, Emma Louise Dempster, Stefania S S Policicchio, Rebecca G. Smith, Ehsan Pishva, Barry A. Chioza, Jonathan P. Davies, Joe Burrage, Katie Lunnon, Dorothea Seiler Vellame et al. · 2022 · Nature Communications
92. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology
    Haure-Mirande, Jean-Vianney, Audrain, Mickael, Fanutza, Tomas, Kim, Soong Ho, Klein, William L., Glabe, Charles, Readhead, Ben, Dudley, Joel T., Blitzer, Robert D., Wang, Minghui et al. · 2017 · Acta Neuropathologica
93. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
    Alison E. Mungenast, Sandra Siegert, Li‐Huei Tsai · 2015 · Molecular and Cellular Neuroscience
94. Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?
    Sami Piirainen, Andrew M. Youssef, Cai Song, Allan V. Kalueff, Gary E. Landreth, Tarja Malm, Li Tian · 2017 · Neuroscience & Biobehavioral Reviews
95. Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s disease
    Qi Zhang, Cheng Ma, Lih‐Shen Chin, Lian Li · 2020 · Science Advances
96. GWAS and ExWAS of blood mitochondrial DNA copy number identifies 71 loci and highlights a potential causal role in dementia
    Michael Chong, Pedrum Mohammadi‐Shemirani, Nicolas Perrot, Walter Nelson, Robert W. Morton, Sukrit Narula, Ricky Lali, Irfan I. Khan, Mohammad Daud Khan, Conor S. Judge et al. · 2022 · eLife
97. Targeting innate immunity for neurodegenerative disorders of the central nervous system
    Andreasson, Katrin I., Bachstetter, Adam D., Colonna, Marco, Ginhoux, Florent, Holmes, Clive, Lamb, Bruce, Landreth, Gary, Lee, Daniel C., Low, Donovan, Lynch, Marina A. et al. · 2016 · Journal of Neurochemistry
98. The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume
    Michelle K. Lupton, Lachlan T. Strike, Narelle K. Hansell, Wei Xiong Wen, Karen A. Mather, Nicola J. Armstrong, Anbupalam Thalamuthu, Katie Louise McMahon, Greig Ian de Zubicaray, Amelia A. Assareh et al. · 2016 · Neurobiology of Aging
99. Major review: Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology
    Inas F. Aboobakar, William M. Johnson, William Daniel Stamer, Michael A. Hauser, R. Rand Allingham · 2016 · Experimental Eye Research
100. Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study
     Vincent Antoine Chouraki, Sarah R. Preis, Qiong Yang, Alexa Beiser, Shuo Li, Martin G. Larson, Galit Weinstein, Thomas J. Wang, Robert Edgardo Gerszten, Ramachandran Srini Vasan et al. · 2017 · Alzheimer s & Dementia